AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

NCT06137118 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia (B-ALL)

Interventions

DRUG: AZD0486

Sponsor

AstraZeneca